Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.055 USD | +2.86% | +2.17% | -27.43% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.43% | 665M | |
+28.28% | 48.16B | |
-0.29% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.00% | 25.59B | |
-22.78% | 18.96B | |
+8.46% | 12.92B | |
+29.82% | 12.03B | |
-2.12% | 11.77B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- JMP Securities Adjusts Price Target on CureVac to $34 From $37, Maintains Market Outperform Rating